RHeference
  • Allele
    • List
    • Search
  • References
    • All
    • By Author
    • By Journal
  • Documentation
  • Statistics
  • Search
    • By name
    • By mutation
    • In exons
    • Complex
  • Contact

References

  1. Vege S et al. Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles. Transfusion, 2021. [Citation] [RHeference]
  2. Matteocci A et al. Two new RHD alleles with deletions spanning multiple exons. Transfusion, 2021. [Citation] [RHeference]
  3. Safic Stanic H et al. D variants in the population of D-negative blood donors in the north-eastern region of Croatia. Transfus Med, 2021. [Citation] [RHeference]
  4. Lyu H et al. A novel RHD allele caused by c.739 G> C mutation was identified in a Chinese individual. Transfusion, 2021. [Citation] [RHeference]
  5. Floch A et al. Comment from Rheference Online ressource, 2020. — Online ressource — [RHeference]
  6. Stettler J et al. Reduced RhD antigen expression caused by two novel RHD variant alleles. Transfusion, 2020. [Citation] [RHeference]
  7. Mufarrege N et al. The novel RHD c.325A>G single nucleotide variation found in Argentineans leads to a partial D phenotype. Transfusion, 2020. [Citation] [RHeference]
  8. Mathur G et al. A novel RHD*DAU allele with c.1136C>T (p.Thr379Met) and c.17C>T (p. Pro6Leu). Transfusion, 2020. [Citation] [RHeference]
  9. Srivastava K et al. NG_007494.1(RHD):c.[4A>T;5G>C;6_7insG] with an RhD-negative phenotype. Transfusion, 2020. [Citation] [RHeference]
  10. Aline Floch et al. Understanding anti-D formation in RhD variants through the study of 3D intraprotein interactions manuscript in preparation, 2020. — Article — [RHeference]
  11. Jessica Keller et al. A Novel RHD Variant Identified in Two Pregnant Women with D Typing Discrepancies Transfusion, 2020. — Abstract — [RHeference]
  12. Sunitha Vege et al. Novel RHD Alleles and Predicting Risk for Anti-D Transfusion, 2020. — Abstract — [RHeference]
  13. Sunitha Vege et al. Novel RHCE*ceS with c.462G>T (p. Arg154Ser) Encodes Expression of a D Reactive Epitope Transfusion, 2020. — Abstract — [RHeference]
  14. Stef M et al. RH genotyping by nonspecific quantitative next-generation sequencing. Transfusion, 2020. [Citation] [RHeference]
  15. Chun S et al. A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants. Transfusion, 2020. [Citation] [RHeference]
  16. Thongbut J et al. Comprehensive Molecular Analysis of Serologically D-Negative and Weak/Partial D Phenotype in Thai Blood Donors. Transfus Med Hemother, 2020. [Citation] [RHeference]
  17. Tammi SM et al. Next-generation sequencing of 35 RHD variants in 16 253 serologically D- pregnant women in the Finnish population. Blood Adv, 2020. [Citation] [RHeference]
  18. Deng D et al. Identification of a novel c.94dupA mutation in RHD allele. Transfusion, 2020. [Citation] [RHeference]
  19. Perez-Alvarez I et al. RHD genotyping of serologic RhD-negative blood donors in a hospital-based blood donor center. Transfusion, 2019. [Citation] [RHeference]
  20. Zhu Y et al. A new RHD variant allele in Exon 2 identified in a Chinese individual. Transfusion, 2019. [Citation] [RHeference]
  21. Qian C et al. A new RhD variant allele is caused by a RhD 26 T > G mutation in a Chinese Han woman with a weak D phenotype. Transfusion, 2019. [Citation] [RHeference]
  22. de Paula Vendrame TA et al. Characterization of RHD alleles present in serologically RHD-negative donors determined by a sensitive microplate technique. Vox Sang, 2019. [Citation] [RHeference]
  23. Zhang X et al. Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China. J Transl Med, 2019. [Citation] [RHeference]
  24. Pisacka M et al. After 70 years, serological RhD determination remains a challenge: DNA to the rescue ISBT Science Series, 2019. — Article — [RHeference]
  25. Sandler SG et al. Does transfusion of Asian-type DEL red blood cells to D- recipients cause D alloimmunization? Transfusion, 2019. [Citation] [RHeference]
  26. Kim H et al. Reconsidering RhD positive blood transfusion for Asia type DEL patients. Transfus Apher Sci, 2019. [Citation] [RHeference]
  27. Wagner F. et al. Results of more than ten years testing of RhD negative first time donors by RHD PCR Transfus Med Hemother, 2019. — Abstract — [RHeference]
  28. J Morrison et al. Severe case of haemolytic disease of fetus and newborn occurring in baby who has inherited a novel RHD allele associated with a “partial” RhD positive phenotype Vox Sanguinis, 2019. — Abstract — [RHeference]
  29. L Castilho et al. From genotyping to the functional and clinical interpretation of variations in blood group genes by 3D-protein structure investigation: two novel variant alleles in the RHD gene Vox Sanguinis, 2019. — Abstract — [RHeference]
  30. C von Arx et al. A novel RHD splice donor site mutation leading to a RhD-negative phenotype Vox Sanguinis, 2019. — Abstract — [RHeference]
  31. CS Principi et al. Genetic characterization of the RH haplotype in individuals carrying the RHD*46C DEL allele Vox Sanguinis, 2019. — Abstract — [RHeference]
  32. GA Denomme et al. A novel weak D 4.0-related allele and RHCE*ceCF defines a new rh haplotype in an autologous donor with an antibody to a high frequency antigen Vox Sanguinis, 2019. — Abstract — [RHeference]
  33. L Castilho et al. RHD*weak D type 3 and production of allo-anti-D in a patient with sickle cell disease (SCD)
 Vox Sanguinis, 2019. — Abstract — [RHeference]
  34. M Pisacka et al. Strong pregnancy induced anti-D immunization in del phenotype with RHD*01EL.04 allele Vox Sanguinis, 2019. — Abstract — [RHeference]
  35. Koutsouri T et al. Frequency distribution of RHD alleles among Greek donors with weak D phenotypes demonstrates a distinct pattern in central European countries. Transfus Med, 2019. [Citation] [RHeference]
  36. Izaskun Apraiz et al. Performance Evaluation Study of ID RHD XT as a Molecular Tool for RHD Gene Screening in Pooled Blood Samples of Serologically D− C/E+ Donors Transfusion, 2019. — Abstract — [RHeference]
  37. Trina Horn et al. Four Novel RHD Alleles Identified Through Investigation of Discrepant or Weak D Status Transfusion, 2019. — Abstract — [RHeference]
  38. Trina Horn et al. Two New RHD*Dau family Alleles Found in Three African American Patients Transfusion, 2019. — Abstract — [RHeference]
  39. Richard Garrett et al. Novel RHD-CE-D Hybrid Allele Associated With D- C+ Phenotype Transfusion, 2019. — Abstract — [RHeference]
  40. Matzhold EM et al. RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expression. Transfusion, 2019. [Citation] [RHeference]
  41. Sunitha Vege et al. Novel RHD Alleles Identified When Resolving Serologic Weak D Phenotypes Transfusion, 2019. — Abstract — [RHeference]
  42. Takeuchi-Baba C et al. Production of RBC autoantibody mimicking anti-D specificity following transfusion in a patient with weak D Type 15. Transfusion, 2019. [Citation] [RHeference]
  43. Raud L et al. Weak D type 1, 2 and 3 subtype alleles are rare in the Western French population. Transfus Med, 2019. [Citation] [RHeference]
  44. Westhoff CM et al. Experience with RHD*weak D type 4.0 in the USA. Blood Transfus, 2019. [Citation] [RHeference]
  45. Silva-Malta MCF et al. Molecular analysis of the RHD pseudogene by duplex real-time polymerase chain reaction. Transfus Med, 2019. [Citation] [RHeference]
  46. Flegel WA et al. A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes. Blood Transfus, 2019. [Citation] [RHeference]
  47. Trucco Boggione C et al. Characterization of RHD locus polymorphism in D negative and D variant donors from Northwestern Argentina. Transfusion, 2019. [Citation] [RHeference]
  48. Schoeman EM et al. Comprehensive blood group antigen profile predictions for Western Desert Indigenous Australians from whole exome sequence data. Transfusion, 2019. [Citation] [RHeference]
  49. Guzijan G et al. Implementation of Molecular RHD Typing at Two Blood Transfusion Institutes from Southeastern Europe. Transfus Med Hemother, 2019. [Citation] [RHeference]
  50. Arnoni CP et al. Correlation among automated scores of agglutination, antigen density by flow cytometry and genetics of D variants. Transfus Apher Sci, 2019. [Citation] [RHeference]
  51. El Housse H et al. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors. Blood Transfus, 2019. [Citation] [RHeference]
  52. de Paula Vendrame TA et al. Novel RHD alleles in African Brazilians. Transfusion, 2019. [Citation] [RHeference]
  53. He Y et al. [A case with a novel weak D type]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2019. [Citation] [RHeference]
  54. Kim B et al. Application of Multiplex Ligation-Dependent Probe Amplification Assay for Genotyping Major Blood Group Systems Including DEL Variants in the D-Negative Korean Population. Ann Lab Med, 2018. [Citation] [RHeference]
  55. Kulkarni SS et al. RHD-Positive Alleles among D- C/E+ Individuals from India. Transfus Med Hemother, 2018. [Citation] [RHeference]
  56. Matteocci A et al. Two novel RHD alleles encoding truncated, nonfunctional D polypeptides. Transfusion, 2018. [Citation] [RHeference]
  57. Turley E et al. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31). Transfusion, 2018. [Citation] [RHeference]
  58. Dezan MR et al. High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype. J Clin Lab Anal, 2018. [Citation] [RHeference]
  59. Chun S et al. The synonymous nucleotide substitution RHD 1056C>G alters mRNA splicing associated with serologically weak D phenotype. J Clin Lab Anal, 2018. [Citation] [RHeference]
  60. Lopez GH et al. A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms. Transfusion, 2018. [Citation] [RHeference]
  61. Srivastava K et al. Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes. J Hum Genet, 2018. [Citation] [RHeference]
  62. S. Lewis et al. Identification of a novel D variant I157S in a patient with alloanti-D Transfusion Medicine, 2018. — Abstract — [RHeference]
  63. M. Ines Moser et al. A new RhD variant: DLO-Like? Transfusion Medicine, 2018. — Abstract — [RHeference]
  64. Schoeman EM et al. Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory setting. Transfusion, 2018. [Citation] [RHeference]
  65. C Vrignaud et al. A Novel RHCE Allele Expressing RHD Epitopes Responsible for a False-Positive D Typing and Post-Transfusion Anti-D Alloimmunization in a Patient of Western European Descent Transfusion, 2018. — Abstract — [RHeference]
  66. J Aeschlimann et al. Serological and Molecular Characterization of Three New RHD Alleles Transfusion, 2018. — Abstract — [RHeference]
  67. V L. Thonier et al. Complex Antibody Mixture in a Pregnant Woman Harboring the RHD*DIIIb Variant Allele Transfusion, 2018. — Abstract — [RHeference]
  68. C Araujo et al. Serological and Molecular Characterization of Weak D Type 18 in Four Brazilian Families Transfusion, 2018. — Abstract — [RHeference]
  69. J S. Woo et al. Robust Allo-Anti-D with Subsequent Anti-K Production after Transfusion of D-Positive RBCs to a Patient with Weak D Type 1 Transfusion, 2018. — Abstract — [RHeference]
  70. Jérôme Babinet et al. Erratum à l’article : « Résumés des Posters » [Transfus. Clin. Biol. 24 (2017) 3S] Transfusion Clinique et Biologique, 2018. — Abstract — [RHeference]
  71. Aparecida de Paula Vendrame T et al. Molecular characterization of three novel RHD alleles in Brazilians. Transfusion, 2018. [Citation] [RHeference]
  72. Aeschlimann J et al. Four novel silenced RHCE. Transfusion, 2018. [Citation] [RHeference]
  73. M Pisacka et al. Two novel partial D antigens, characterized by single missense nontemplated mutations causing a significant impact on RHD protein tertial structure and d epitopes expression Vox Sanguinis, 2018. — Abstract — [RHeference]
  74. Tounsi WA et al. Complete RHD next-generation sequencing: establishment of reference RHD alleles. Blood Adv, 2018. [Citation] [RHeference]
  75. Bub CB et al. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization. J Clin Lab Anal, 2018. [Citation] [RHeference]
  76. Ouchari M et al. Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia. Transfusion, 2018. [Citation] [RHeference]
  77. Srivastava K et al. Two distinct RHCE alleles in cis to weak D type 31 alleles in individuals from different ethnicities. Transfusion, 2018. [Citation] [RHeference]
  78. Fichou Y et al. Molecular basis of weak D expression in the Indian population and report of a novel, predominant variant RHD allele. Transfusion, 2018. [Citation] [RHeference]
  79. Liao Z et al. [A weak D type 59 case identified in the Chinese Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2018. [Citation] [RHeference]
  80. de Brevern AG et al. Alloimmunization risk associated with amino acid 223 substitution in the RhD protein: analysis in the light of molecular modeling. Transfusion, 2018. [Citation] [RHeference]
  81. Polin H et al. Identification of four novel RHD alleles by weakened antigen D expression. Transfusion, 2018. [Citation] [RHeference]
  82. Xu HY et al. [Identification of Phenotype and Genotype in One Case with Weak D blood group]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2018. [Citation] [RHeference]
  83. Zhang J et al. Identification of a novel missense mutation (p.Ser230Asn) in RHD allele in a Chinese individual with partial D phenotype. Transfusion, 2018. [Citation] [RHeference]
  84. Dezan MR et al. Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*Ψ. Transfusion, 2018. [Citation] [RHeference]
  85. Raud L et al. From genetic variability to phenotypic expression of blood group systems. Transfus Clin Biol, 2017. [Citation] [RHeference]
  86. Hyland CA et al. Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types. Pathology, 2017. [Citation] [RHeference]
  87. Fennell K et al. Effect on gene expression of three allelic variants in GATA motifs of ABO, RHD, and RHCE regulatory elements. Transfusion, 2017. [Citation] [RHeference]
  88. El Wafi M et al. Novel intronic RHD variants identified in serologically D-negative blood donors. Vox Sang, 2017. [Citation] [RHeference]
  89. Boggione CT et al. Genotyping approach for non-invasive foetal RHD detection in an admixed population. Blood Transfus, 2017. [Citation] [RHeference]
  90. Bruno Costes et al. c.1154-31C>T Is in Linkage Disequilibrium with the Missense Mutation C.1154G>C on RHD Weak Type 2 Transfusion, 2017. — Abstract — [RHeference]
  91. Granier T et al. First description of a D-CE-D hybrid gene on a weak D Type 2 molecular background. Transfusion, 2017. [Citation] [RHeference]
  92. Chou ST et al. Application of genomics for transfusion therapy in sickle cell anemia. Blood Cells Mol Dis, 2017. [Citation] [RHeference]
  93. Duncan JA et al. Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D. Immunohematology, 2017. [Citation] [RHeference]
  94. J P Hudgins et al. Serologic and Molecular Classification of a Novel RHD Allele Transfusion, 2017. — Abstract — [RHeference]
  95. S Vege et al. Expansion of the RHD DAU Cluster: Identification of Two Additional Novel Alleles Transfusion, 2017. — Abstract — [RHeference]
  96. S Vege et al. Serologic Characterization of D Antigen Expression Encoded By Two Reported RHD Alleles: Implications for Transfusion and Pregnancy Transfusion, 2017. — Abstract — [RHeference]
  97. S Vege et al. RHD Genotyping of Discrepant or Weak D Samples: Over a Year’s Experience. Transfusion, 2017. — Abstract — [RHeference]
  98. J Aeschlimann et al. Gene Conversion within the r’S Haplotype Complicates RHD Genotype Interpretations Transfusion, 2017. — Abstract — [RHeference]
  99. Floch A et al. Molecular characterization of 13 new RHD alleles. Transfusion, 2017. [Citation] [RHeference]
  100. Jérôme Babinet et al. Inscription des individus RH : −1, −4 ou RH : −1, −5 dans le registre national de référence des sujets présentant un phénotype/génotype érythrocytaire rare : intérêt de la réalisation d’une PCR multiplexe systématique pour le dépistage des variants RH1 affaiblis non détectés par sérologie de routine Transfusion Clinique et Biologique, 2017. — Abstract — [RHeference]
  101. Quantock KM et al. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn. Transfusion, 2017. [Citation] [RHeference]
  102. A Matteocci et al. Identification of weak D type 100 in two unrelated italian donors Vox Sanguinis, 2017. — Abstract — [RHeference]
  103. Thongbut J et al. RHD-specific microRNA for regulation of the DEL blood group: integration of computational and experimental approaches. Br J Biomed Sci, 2017. [Citation] [RHeference]
  104. Ji YL et al. RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay. Vox Sang, 2017. [Citation] [RHeference]
  105. Dezan MR et al. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells Mol Dis, 2017. [Citation] [RHeference]
  106. Ouchari M et al. Serologic and molecular characterization of weak D type 29. Transfusion, 2017. [Citation] [RHeference]
  107. Anani WQ et al. Molecular characterization of three novel weak D type alleles with additional haplotype data on weak D Types 1.2 and 18. Transfusion, 2017. [Citation] [RHeference]
  108. McGowan EC et al. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management. Vox Sang, 2017. [Citation] [RHeference]
  109. Lopez GH et al. Genotyping by sequencing defines independent novel RHD variants for an antenatal patient and a blood donor. Transfusion, 2017. [Citation] [RHeference]
  110. Feng J et al. A new RHD variant allele is caused by a RHD 662C>G mutation. Transfusion, 2017. [Citation] [RHeference]
  111. Chou ST et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv, 2017. [Citation] [RHeference]
  112. Luo H et al. [Phenotype Types and Genetic Mutation Mechanism of Rhesus D Variant Individuals]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2017. [Citation] [RHeference]
  113. Saleheen D et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature, 2017. [Citation] [RHeference]
  114. Seo MH et al. An effective diagnostic strategy for accurate detection of RhD variants including Asian DEL type in apparently RhD-negative blood donors in Korea. Vox Sang, 2016. [Citation] [RHeference]
  115. Zacarias JM et al. Frequency of RHD variants in Brazilian blood donors from Parana State, Southern Brazil. Transfus Apher Sci, 2016. [Citation] [RHeference]
  116. Vege S et al. D typing discrepancies and anti-D production associated with six new RHD alleles. Transfusion, 2016. — Abstract — [RHeference]
  117. Goldman M et al. Identification of six new RHCE variant alleles in individuals of diverse racial origin. Transfusion, 2016. [Citation] [RHeference]
  118. Chen DP et al. Comprehensive analysis of RHD splicing transcripts reveals the molecular basis for the weak anti-D reactivity of Del -red blood cells. Transfus Med, 2016. [Citation] [RHeference]
  119. Lopez GH et al. A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype. Transfusion, 2016. [Citation] [RHeference]
  120. Clarke G et al. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients. Transfusion, 2016. [Citation] [RHeference]
  121. Arnoni CP et al. Identification of four novel RHD alleles with altered expression of D in Brazilians. Transfusion, 2016. [Citation] [RHeference]
  122. Zhao H et al. A serologic weakly reactive RhD is caused by a c.496C>G (p.His166Asp) in RHD gene. Transfusion, 2016. [Citation] [RHeference]
  123. C Nixon et al. A Patient with Weak D Type 3 and Anti-D Alloimmunization Transfusion, 2016. — Abstract — [RHeference]
  124. Lukacevic Krstic J et al. Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD. Transfus Med Hemother, 2016. [Citation] [RHeference]
  125. C Henny et al. Impact of the mandatory donor RHD screening in Switzerland Vox Sanguinis, 2016. — Abstract — [RHeference]
  126. Karnot A. et al. Weak RhD phenotype caused by compound heterozygosity for DAU-2 and a new RHD*c393-394 dupGG-mutation Transfus Med Hemother, 2016. — Abstract — [RHeference]
  127. Stegmann TC et al. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Br J Haematol, 2016. [Citation] [RHeference]
  128. Srivastava K et al. The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens. Transfusion, 2016. [Citation] [RHeference]
  129. Yazer MH et al. Low incidence of D alloimmunization among patients with a serologic weak D phenotype after D+ transfusion. Transfusion, 2016. [Citation] [RHeference]
  130. Ogasawara K et al. Weak D alleles in Japanese: a c.960G>A silent mutation in exon 7 of the RHD gene that affects D expression. Vox Sang, 2016. [Citation] [RHeference]
  131. Isa K et al. Prevalence of RHD alleles in Japanese individuals with weak D phenotype: Identification of 20 new RHD alleles. Vox Sang, 2016. [Citation] [RHeference]
  132. Costa SS et al. RHD*weak D type 38: a family study. Rev Bras Hematol Hemoter, 2016. [Citation] [RHeference]
  133. Trucco Boggione C et al. Weak D antigen expression caused by a novel RHD allele in Argentineans. Transfusion, 2016. [Citation] [RHeference]
  134. Filosa L et al. New silent and weak D alleles: molecular characterization and associated antigen density. Transfusion, 2016. [Citation] [RHeference]
  135. Möller M et al. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv, 2016. [Citation] [RHeference]
  136. Polin H et al. RHD Tyr311Stop encoded by a novel nonsense mutation. Transfusion, 2016. [Citation] [RHeference]
  137. Quaglietta A et al. Case-report of a newly described RHD allele Vox Sanguinis, 2015. — Abstract — [RHeference]
  138. A C Gaspardi et al. RHD variants in blood donors from Southeast Brazil. Transfusion, 2015. — Abstract — [RHeference]
  139. Moser I et al. A novel RHD allele resulting in a weak D variant Vox Sanguinis, 2015. — Abstract — [RHeference]
  140. He J et al. Molecular basis and zygosity determination of D variants including identification of four novel alleles in Chinese individuals. Transfusion, 2015. [Citation] [RHeference]
  141. Fichou Y et al. Extensive functional analyses of RHD splice site variants: Insights into the potential role of splicing in the physiology of Rh. Transfusion, 2015. [Citation] [RHeference]
  142. Lambert MD et al. The second example of alloanti-D in a weak D type 33 individual Vox Sanguinis, 2015. — Abstract — [RHeference]
  143. Wang M et al. Anti-D alloimmunisation in pregnant women with DEL phenotype in China. Transfus Med, 2015. [Citation] [RHeference]
  144. Xu W et al. Prospective Evaluation of a Transfusion Policy of RhD-Positive Red Blood Cells into DEL Patients in China. Transfus Med Hemother, 2015. [Citation] [RHeference]
  145. Yang HS et al. Primary anti-D alloimmunization induced by "Asian type" RHD (c.1227G>A) DEL red cell transfusion. Ann Lab Med, 2015. [Citation] [RHeference]
  146. Costa SSM et al. Management of Blood Transfusion in a Patient Carrying Anti-Rh18 Associated with the RHD*Weak D 4.2.2/RHCE*ceAR Haplotype Blood Disorders & Transfusion, 2015. — Article — [RHeference]
  147. Ipe TS et al. Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease. J Pediatr Hematol Oncol, 2015. [Citation] [RHeference]
  148. Garcia F et al. New RHD variant alleles. Transfusion, 2015. [Citation] [RHeference]
  149. Van Sandt VS et al. RHD variants in Flanders, Belgium. Transfusion, 2015. [Citation] [RHeference]
  150. Kacem N et al. Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests. Blood Transfus, 2015. [Citation] [RHeference]
  151. Ba A et al. RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2). Transfusion, 2015. [Citation] [RHeference]
  152. Sippert E et al. Variant RH alleles and Rh immunisation in patients with sickle cell disease. Blood Transfus, 2015. [Citation] [RHeference]
  153. Ouchari M et al. Weak D in the Tunisian population. Blood Transfus, 2015. [Citation] [RHeference]
  154. Sandler SG et al. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion, 2015. [Citation] [RHeference]
  155. Zhang X et al. [Molecular mechanism of 101A>G and 845G>A mutations of RHD gene responsible for a weak RhD]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2015. [Citation] [RHeference]
  156. Ogasawara K et al. Molecular basis for D- Japanese: identification of novel DEL and D- alleles. Vox Sang, 2015. [Citation] [RHeference]
  157. Berardi P et al. Weak D type 67 in four related Canadian blood donors. Immunohematology, 2015. [Citation] [RHeference]
  158. Flesch BK et al. A serologic weakly reactive RhD is caused by a RHD 374T>A (Ile125Asn). Transfusion, 2015. [Citation] [RHeference]
  159. Haspel RL et al. How do I manage Rh typing in obstetric patients? Transfusion, 2015. [Citation] [RHeference]
  160. Ye SH et al. A comprehensive investigation of RHD polymorphisms in the Chinese Han population in Xi'an. Blood Transfus, 2014. [Citation] [RHeference]
  161. Arnoni CP et al. How do we identify RHD variants using a practical molecular approach? Transfusion, 2014. [Citation] [RHeference]
  162. Gu J et al. Analysis of density and epitopes of D antigen on the surface of erythrocytes from DEL phenotypic individuals carrying the RHD1227A allele. Blood Transfus, 2014. [Citation] [RHeference]
  163. B. Just et al. Secondary Anti-D Immunization of a D-Negative Recipient by Del Red Cell Concentrate Transfusionsmedizin, 2014. — Article — [RHeference]
  164. Gu J et al. Molecular basis of DEL phenotype in the Chinese population. BMC Med Genet, 2014. [Citation] [RHeference]
  165. Wagner FF et al. The Rhesus Site. Transfus Med Hemother, 2014. [Citation] [RHeference]
  166. C M Westhoff et al. A Weak D Phenotype Discovered in Nine Patients in Western Canada due to a Nucleotide 1187C>G (Pro396Arg) Change in RHD Transfusion, 2014. — Abstract — [RHeference]
  167. G Shakarian et al. Three New, Clinically Relevant RHD genes Transfusion, 2014. — Abstract — [RHeference]
  168. J A Crowley et al. Two New RH Hybrid Genes and Their Potential Role in Pregnancy Transfusion, 2014. — Abstract — [RHeference]
  169. N Robitaille et al. A New Weak RHD Allele in North Africans Transfusion, 2014. — Abstract — [RHeference]
  170. Reid ME et al. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cells Mol Dis, 2014. [Citation] [RHeference]
  171. Jakobsen MA et al. A case of high-titer anti-D hemolytic disease of the newborn in which late onset and mild course is associated with the D variant, RHD-CE(9)-D. Transfusion, 2014. [Citation] [RHeference]
  172. Kappler-Gratias S et al. Systematic RH genotyping and variant identification in French donors of African origin. Blood Transfus, 2014. [Citation] [RHeference]
  173. Flegel WA et al. Phasing-in RHD genotyping. Arch Pathol Lab Med, 2014. [Citation] [RHeference]
  174. Ouchari M et al. Anti-D auto-immunization in a patient with weak D type 4.0. Transfus Clin Biol, 2014. [Citation] [RHeference]
  175. Gowland P et al. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci, 2014. [Citation] [RHeference]
  176. Costa S et al. RHD alleles and D antigen density among serologically D- C+ Brazilian blood donors. Transfus Med, 2014. [Citation] [RHeference]
  177. Scott SA et al. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes. Transfusion, 2014. [Citation] [RHeference]
  178. Lin F et al. [Molecular genetic analysis of a weak D phenotype]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2014. [Citation] [RHeference]
  179. Xhetani M et al. Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania. Blood Transfus, 2014. [Citation] [RHeference]
  180. Crottet SL et al. Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci, 2014. [Citation] [RHeference]
  181. Trucco Boggione C et al. Molecular structures identified in serologically D- samples of an admixed population. Transfusion, 2014. [Citation] [RHeference]
  182. Wang QP et al. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population. Blood Transfus, 2014. [Citation] [RHeference]
  183. Tsui NB et al. Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allele. Prenat Diagn, 2013. [Citation] [RHeference]
  184. Orzińska A et al. RHD variants in Polish blood donors routinely typed as D-. Transfusion, 2013. [Citation] [RHeference]
  185. Ouchari M et al. RHD alleles in the Tunisian population. Asian J Transfus Sci, 2013. [Citation] [RHeference]
  186. Ouchari M et al. [System RH: screening of partials D with RHD/RHCE hybrid gene]. Transfus Clin Biol, 2013. [Citation] [RHeference]
  187. Lejon Crottet S et al. Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA. Transfusion, 2013. [Citation] [RHeference]
  188. Goldman M et al. Identifying D-positive donors using a second automated testing platform. Immunohematology, 2013. [Citation] [RHeference]
  189. Fichou Y et al. A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. Transfusion, 2013. [Citation] [RHeference]
  190. Silvy M et al. Identification of novel polymorphism restricted to the (C)ces type 1 haplotype avoids risk of transfusion deadlock in SCD patients. Br J Haematol, 2013. [Citation] [RHeference]
  191. Reid ME et al. The low-prevalence Rh antigen STEM (RH49) is encoded by two different RHCE*ce818T alleles that are often in cis to RHD*DOL. Transfusion, 2013. [Citation] [RHeference]
  192. von Zabern I et al. D category IV: a group of clinically relevant and phylogenetically diverse partial D. Transfusion, 2013. [Citation] [RHeference]
  193. Westhoff CM et al. RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa. Transfusion, 2013. [Citation] [RHeference]
  194. Roussel M et al. RHD*DOL1 and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent. Transfusion, 2013. [Citation] [RHeference]
  195. Ye L et al. Weak D phenotypes caused by intronic mutations in the RHD gene: four novel weak D alleles identified in the Chinese population. Transfusion, 2013. [Citation] [RHeference]
  196. Chen JM et al. Small deletions within the RHD coding sequence: a report of two novel mutational events and a survey of the underlying pathophysiologic mechanisms. Transfusion, 2013. [Citation] [RHeference]
  197. Westhoff CM et al. RHCE*ceMO is frequently in cis to RHD*DAU0 and encodes a hr(S) -, hr(B) -, RH:-61 phenotype in black persons: clinical significance. Transfusion, 2013. [Citation] [RHeference]
  198. Chou ST et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood, 2013. [Citation] [RHeference]
  199. Abdelrazik AM et al. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt. Transfusion, 2013. [Citation] [RHeference]
  200. Haer-Wigman L et al. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification. Transfusion, 2013. [Citation] [RHeference]
  201. Daniels G et al. Variants of RhD--current testing and clinical consequences. Br J Haematol, 2013. [Citation] [RHeference]
  202. O'Suoji C et al. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer, 2013. [Citation] [RHeference]
  203. Granier T et al. A comprehensive survey of both RHD and RHCE allele frequencies in sub-Saharan Africa. Transfusion, 2013. [Citation] [RHeference]
  204. Hussein E et al. Weak D types in the Egyptian population. Am J Clin Pathol, 2013. [Citation] [RHeference]
  205. Gassner C et al. Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76. Transfusion, 2013. [Citation] [RHeference]
  206. Fichou Y et al. Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion, 2013. [Citation] [RHeference]
  207. Pham BN et al. Molecular analysis of patients with weak D and serologic analysis of those with anti-D (excluding type 1 and type 2). Immunohematology, 2013. [Citation] [RHeference]
  208. Gardener GJ et al. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion, 2012. [Citation] [RHeference]
  209. Hipsky CH et al. Molecular basis of the rare gene complex, DIVa(C)-, which encodes four low-prevalence antigens in the Rh blood group system. Vox Sang, 2012. [Citation] [RHeference]
  210. St-Louis R et al. DEL Blood donors alloimmunised patients: the Canadian experience Vox Sanguinis, 2012. — Abstract — [RHeference]
  211. Wagner FF et al. RHD PCR of blood donors in Northern Germany: use of adsorption/elution to determine D antigen status Vox Sanguinis, 2012. — Abstract — [RHeference]
  212. Moussa H et al. Molecular background of D-negative phenotype in the Tunisian population. Transfus Med, 2012. [Citation] [RHeference]
  213. Duran JA et al. New RHD variant found in Portuguese blood donors Vox Sanguinis, 2012. — Abstract — [RHeference]
  214. Horn T et al. RHD*DIII.4 allele with additional nucleotide change 307 T>C Vox Sanguinis, 2012. — Abstract — [RHeference]
  215. Szulman A et al. Investigation of pseudogenes RHDΨ and RHD-CE-D hybrid gene in D-negative blood donors by the real time PCR method. Transfus Apher Sci, 2012. [Citation] [RHeference]
  216. C Fong et al. An RHD*455C Allele Encodes a Partial D Phenotype Associated With Production of Allo Anti-D Transfusion, 2012. — Abstract — [RHeference]
  217. Mota M et al. RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA. J Clin Lab Anal, 2012. [Citation] [RHeference]
  218. M E Reid et al. DIVa and DIVa-2 are Encoded by the Same RHD Allele Transfusion, 2012. — Abstract — [RHeference]
  219. Villa MA et al. A novel mutation of the RHD antigen Vox Sanguinis, 2012. — Abstract — [RHeference]
  220. Shao CP et al. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B, 2012. [Citation] [RHeference]
  221. Reid ME et al. Molecular background of RH in Bastiaan, the RH:-31,-34 index case, and two novel RHD alleles. Immunohematology, 2012. [Citation] [RHeference]
  222. Fichou Y et al. Weak D caused by a founder deletion in the RHD gene. Transfusion, 2012. [Citation] [RHeference]
  223. Silvy M et al. Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture. Transfusion, 2012. [Citation] [RHeference]
  224. Fichou Y et al. Variant screening of the RHD gene in a large cohort of subjects with D phenotype ambiguity: report of 17 novel rare alleles. Transfusion, 2012. [Citation] [RHeference]
  225. M. Ines Moser et al. Weak D Type 38 or Weak D Type 79? Transfusion Medicine, 2012. — Abstract — [RHeference]
  226. M St-Louis et al. Two New RHD Variants: 717C>A and 254C>T Transfusion, 2012. — Abstract — [RHeference]
  227. F F Wagner et al. Single Adsorption / Elution with Anti-D May Be Insufficient to Determine the D Antigen Status of Very Weak DEL Alleles Transfusion, 2012. — Abstract — [RHeference]
  228. Ye L et al. Partial D phenotypes and genotypes in the Chinese population. Transfusion, 2012. [Citation] [RHeference]
  229. Rizzo C et al. Weak D and partial D: our experience in daily activity. Blood Transfus, 2012. [Citation] [RHeference]
  230. von Zabern I et al. DFR-5 is a New Member in the DFR Family of Partial D and Has the Hybrid Structure RHD-CE(3-4)-D Transfus Med Hemother, 2012. — Abstract — [RHeference]
  231. Sandler SG et al. New laboratory procedures and Rh blood type changes in a pregnant woman. Obstet Gynecol, 2012. [Citation] [RHeference]
  232. Lomas-Francis C et al. DIII Type 7 is likely the original serologically defined DIIIb. Transfusion, 2012. [Citation] [RHeference]
  233. Chen JM et al. Local sequence determinants of two in-frame triplet deletion/duplication hotspots in the RHD/RHCE genes. Hum Genomics, 2012. [Citation] [RHeference]
  234. Flegel WA et al. Allo- and autoanti-D in weak D types and in partial D. Transfusion, 2012. [Citation] [RHeference]
  235. Yazer MH et al. Anti-D alloimmunization propensity cannot be determined without information on D antigen exposure. Transfusion, 2012. [Citation] [RHeference]
  236. Cruz BR et al. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med, 2012. [Citation] [RHeference]
  237. Polin H et al. On the trail of anti-CDE to unexpected highlights of the RHD*weak 4.3 allele in the Upper Austrian population. Vox Sang, 2012. [Citation] [RHeference]
  238. Brajovich ME et al. Comprehensive analysis of RHD alleles in Argentineans with variant D phenotypes. Transfusion, 2012. [Citation] [RHeference]
  239. Chen Q et al. Molecular basis of weak D and DEL in Han population in Anhui Province, China. Chin Med J (Engl), 2012. [Citation] [RHeference]
  240. Wagner FF and Flegel WA et al. The Human RhesusBase Online ressource, 2011. — Online ressource — [RHeference]
  241. Xu H et al. [Molecular study of two novel RHD alleles and pedigree analysis]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2011. [Citation] [RHeference]
  242. Hipsky CH et al. RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford. Transfusion, 2011. [Citation] [RHeference]
  243. Silvy M et al. Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles. Transfusion, 2011. [Citation] [RHeference]
  244. S Vege et al. Weak D Type 2 and Production of Anti-D Transfusion, 2011. — Abstract — [RHeference]
  245. D. Bruce et al. Immune Alloanti-D in a Patient With Weak D Type 33 Genotype Transfusion Medicine, 2011. — Abstract — [RHeference]
  246. Yukari Nishiyama et al. A case of suspected partial D because of weak reactivity to anti-D on column agglutination technology and identified as partial D (DBT-1) by genetic testing Japanese Journal of Transfusion and Cell Therapy, 2011. — Article — [RHeference]
  247. S. Grimsley et al. Three Novel RHD Variants Including One with Anti-D Transfusion Medicine, 2011. — Abstract — [RHeference]
  248. C Lomas-Francis et al. Surprising findings with RBCs expressing the low prevalence RH antigen Evans Transfusion, 2011. — Abstract — [RHeference]
  249. St-Louis M et al. Weak D type 42 cases found in individuals of European descent. Immunohematology, 2011. [Citation] [RHeference]
  250. Hue-Roye K et al. Red cells from the original JAL+ proband are also DAK+ and STEM+. Vox Sang, 2011. [Citation] [RHeference]
  251. Green C et al. Evidence that a mutation in a splice site of RHD intron 2 causes alternative splicing of RHD exon 3 Vox Sanguinis, 2011. — Abstract — [RHeference]
  252. Noizat-Pirenne F et al. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol, 2011. [Citation] [RHeference]
  253. Pham BN et al. Anti-D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo- or autoantibodies? Transfusion, 2011. [Citation] [RHeference]
  254. Dogic V et al. Distribution of weak D types in the Croatian population. Transfus Med, 2011. [Citation] [RHeference]
  255. Krog GR et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion, 2011. [Citation] [RHeference]
  256. Stabentheiner S et al. Overcoming methodical limits of standard RHD genotyping by next-generation sequencing. Vox Sang, 2011. [Citation] [RHeference]
  257. Pereira JC et al. RhD variant caused by an in-frame triplet duplication in the RHD gene. Transfusion, 2011. [Citation] [RHeference]
  258. Hua X et al. A new RHD-positive, D antigen negative allele in Chinese. Vox Sang, 2010. [Citation] [RHeference]
  259. Liu HC et al. Aberrant RNA splicing in RHD 7-9 exons of DEL individuals in Taiwan: a mechanism study. Biochim Biophys Acta, 2010. [Citation] [RHeference]
  260. Christiansen M et al. RHD positive among C/E+ and D- blood donors in Denmark. Transfusion, 2010. [Citation] [RHeference]
  261. Shao CP et al. Antenatal Rh prophylaxis is unnecessary for "Asia type" DEL women. Transfus Clin Biol, 2010. [Citation] [RHeference]
  262. Shao CP et al. Transfusion of RhD-positive blood in "Asia type" DEL recipients. N Engl J Med, 2010. [Citation] [RHeference]
  263. Schmid P et al. Specific amino acid substitutions cause distinct expression of JAL (RH48) and JAHK (RH53) antigens in RhCE and not in RhD. Transfusion, 2010. [Citation] [RHeference]
  264. Westhoff CM et al. DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications. Transfusion, 2010. [Citation] [RHeference]
  265. McGann H et al. Alloimmunization to the D antigen by a patient with weak D type 21. Immunohematology, 2010. [Citation] [RHeference]
  266. Pereira J et al. Novel human pathological mutations. Gene symbol: RHD. Disease: reduced expression (weak D). Hum Genet, 2009. [Citation] [RHeference]
  267. S Vege et al. RHD Exon Consensus Splice-Site Changes, 334A>G and 1228T>G, Associated with Weak D Expression Transfusion, 2009. — Abstract — [RHeference]
  268. Polin H et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion, 2009. [Citation] [RHeference]
  269. Flegel WA et al. D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion, 2009. [Citation] [RHeference]
  270. Li Q et al. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang, 2009. [Citation] [RHeference]
  271. Pham BN et al. Heterogeneous molecular background of the weak C, VS+, hr B-, Hr B- phenotype in black persons. Transfusion, 2009. [Citation] [RHeference]
  272. L. Tilley et al. Five Novel RHD Alleles Resulting in D Variant Phenotypes Transfusion Medicine, 2009. — Abstract — [RHeference]
  273. J. Pereira et al. RHD Null Alleles in the Portuguese Population Transfusion Medicine, 2009. — Abstract — [RHeference]
  274. M Rodrigues et al. A novel RHD variant 'DFW-2' Vox Sanguinis, 2009. — Abstract — [RHeference]
  275. Pereira JC et al. Novel human pathological mutations. Gene symbol: RHD. Disease: Rhesus negative blood group. Hum Genet, 2009. [Citation] [RHeference]
  276. Touinssi M et al. Molecular analysis of inactive and active RHD alleles in native Congolese cohorts. Transfusion, 2009. [Citation] [RHeference]
  277. Flegel WA et al. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion, 2009. [Citation] [RHeference]
  278. Ye L et al. Molecular bases of unexpressed RHD alleles in Chinese D- persons. Transfusion, 2009. [Citation] [RHeference]
  279. Pereira J et al. Gene symbol: RHD. Disease: Rhesus negative blood group. Hum Genet, 2008. [Citation] [RHeference]
  280. Li Q et al. Molecular basis of D variants between Uigur and Han blood donors in Xinjiang. Transfus Med, 2008. [Citation] [RHeference]
  281. Kulkarni S et al. Frequency of partial D in Western India. Transfus Med, 2008. [Citation] [RHeference]
  282. Christiansen M et al. Correlation between serology and genetics of weak D types in Denmark. Transfusion, 2008. [Citation] [RHeference]
  283. Flegel WA et al. DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. Transfusion, 2008. [Citation] [RHeference]
  284. Müller SP et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion, 2008. [Citation] [RHeference]
  285. Pereira JC et al. Gene symbol: RHD. Disease: Rhesus blood group variation. Hum Genet, 2008. [Citation] [RHeference]
  286. Pereira JC et al. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience. Prenat Diagn, 2007. [Citation] [RHeference]
  287. Nogues N et al. RHD null alleles in the Spanish population Vox Sanguinis, 2007. — Abstract — [RHeference]
  288. Richard M et al. A new DEL variant caused by exon 8 deletion. Transfusion, 2007. [Citation] [RHeference]
  289. Le Maréchal C et al. Identification of 12 novel RHD alleles in western France by denaturing high-performance liquid chromatography analysis. Transfusion, 2007. [Citation] [RHeference]
  290. Westhoff CM et al. Rh complexities: serology and DNA genotyping. Transfusion, 2007. [Citation] [RHeference]
  291. L. Tilley et al. Four RhD Variants Caused by Novel RhD Mutations Transfusion Medicine, 2007. — Abstract — [RHeference]
  292. L. Tilley et al. Two Novel RhD Variants Caused by Triplet Deletions in the RhD Gene Transfusion Medicine, 2007. — Abstract — [RHeference]
  293. Vaglio S et al. Anti-D in a D-positive patient: autoantibody or alloantibody? Blood Transfus, 2007. [Citation] [RHeference]
  294. Noizat-Pirenne F et al. Weak D phenotypes and transfusion safety: where do we stand in daily practice? Transfusion, 2007. [Citation] [RHeference]
  295. Lomas-Francis C et al. A confusion in antibody identification: anti-D production after anti-hrB. Immunohematology, 2007. [Citation] [RHeference]
  296. MP Martinez Badas et al. Anti-D immunization in a D-positive mother Vox Sanguinis, 2007. — Abstract — [RHeference]
  297. von Zabern I et al. IVS5-38del4 deletion in the RHD gene does not cause a DEL phenotype: relevance for RHD alleles including DFR-3. Transfusion, 2007. [Citation] [RHeference]
  298. Polin H et al. Effective molecular RHD typing strategy for blood donations. Transfusion, 2007. [Citation] [RHeference]
  299. Yan L et al. Molecular basis of D variants in Chinese persons. Transfusion, 2007. [Citation] [RHeference]
  300. Ye LY et al. Molecular and family analyses revealed two novel RHD alleles in a survey of a Chinese RhD-negative population. Vox Sang, 2007. [Citation] [RHeference]
  301. Luettringhaus TA et al. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion, 2006. [Citation] [RHeference]
  302. Wei Qing et al. Random survey for RH allele polymorphism among 50 native Tibetans. Open Access Repositorium of the University of Ulm (Germany), 2006. — Thesis — [RHeference]
  303. W. Etheridge et al. Two Novel D Genes of the Rh Blood Group System Producing D Variant Phenotypes Transfusion Medicine, 2006. — Abstract — [RHeference]
  304. Flegel WA et al. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion, 2006. [Citation] [RHeference]
  305. L. Tilley et al. A Novel RhD Variant Transfusion Medicine, 2006. — Abstract — [RHeference]
  306. Chen Q et al. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion, 2006. [Citation] [RHeference]
  307. M J Rodrigues et al. Several New Examples of Weak D Type 38 in the Portuguese Population Transfusion, 2006. — Abstract — [RHeference]
  308. Flegel WA et al. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol, 2006. [Citation] [RHeference]
  309. Shao CP et al. Multiple isoforms excluding normal RhD mRNA detected in Rh blood group Del phenotype with RHD 1227A allele. Transfus Apher Sci, 2006. [Citation] [RHeference]
  310. Flegel WA et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion, 2006. [Citation] [RHeference]
  311. Yu X et al. Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion, 2006. [Citation] [RHeference]
  312. Grootkerk-Tax MG et al. RHD(T201R, F223V) cluster analysis in five different ethnic groups and serologic characterization of a new Ethiopian variant DARE, the DIII type 6, and the RHD(F223V). Transfusion, 2006. [Citation] [RHeference]
  313. Araújo F et al. Weak D type 2 is the most prevalent weak D type in Portugal. Transfus Med, 2006. [Citation] [RHeference]
  314. Esteban R et al. The D category VI type 4 allele is prevalent in the Spanish population. Transfusion, 2006. [Citation] [RHeference]
  315. Sun GD et al. [Molecular background of weak D type 15 as the predominant weak D type found in Chinese population]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2006. [Citation] [RHeference]
  316. Li Q et al. [Study on the molecular background of Del phenotype in Chinese population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006. [Citation] [RHeference]
  317. Wagner T et al. Anti-D immunization by DEL red blood cells. Transfusion, 2005. [Citation] [RHeference]
  318. D. G. Bruce et al. Immune Alloanti-D in a Patient with a Novel RHD Mutation Transfusion Medicine, 2005. — Abstract — [RHeference]
  319. Kim JY et al. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion, 2005. [Citation] [RHeference]
  320. R. A. Laycock et al. A Case of a DEL Woman Being Immunised to Produce Anti-D which Caused Severe HDFN Transfusion Medicine, 2005. — Abstract — [RHeference]
  321. L. Tilley et al. A novel RhD variant associated with extremely low serological expression of D-antigen Transfusion Medicine, 2005. — Abstract — [RHeference]
  322. Körmöczi GF et al. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types. Transfusion, 2005. [Citation] [RHeference]
  323. Doescher A et al. Weak D type 1.1 exemplifies another complexity in weak D genotyping. Transfusion, 2005. [Citation] [RHeference]
  324. Mota M et al. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Vox Sang, 2005. [Citation] [RHeference]
  325. Körmöczi GF et al. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion, 2005. [Citation] [RHeference]
  326. Chen Q et al. Random survey for RHD alleles among D+ European persons. Transfusion, 2005. [Citation] [RHeference]
  327. Gassner C et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion, 2005. [Citation] [RHeference]
  328. Denomme GA et al. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion, 2005. [Citation] [RHeference]
  329. Xu Q et al. Systemic analysis and zygosity determination of the RHD gene in a D-negative Chinese Han population reveals a novel D-negative RHD gene. Vox Sang, 2005. [Citation] [RHeference]
  330. Shao CP et al. A new hybrid RHD-positive, D antigen-negative allele. Transfus Med, 2004. [Citation] [RHeference]
  331. Chen JC et al. RHD 1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol, 2004. [Citation] [RHeference]
  332. Westhoff CM et al. A new hybrid RHCE gene (CeNR) is responsible for expression of a novel antigen. Transfusion, 2004. [Citation] [RHeference]
  333. Ansart-Pirenne H et al. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion, 2004. [Citation] [RHeference]
  334. Shao C et al. Whole exon 5 and intron 5 replaced by RHCE in DVa(Hus). J Hum Genet, 2004. [Citation] [RHeference]
  335. Körmöczi GF et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion, 2004. [Citation] [RHeference]
  336. Peng CT et al. Molecular basis for the RhD negative phenotype in Chinese. Int J Mol Med, 2003. [Citation] [RHeference]
  337. Wagner FF et al. The RHCE allele ceRT: D epitope 6 expression does not require D-specific amino acids. Transfusion, 2003. [Citation] [RHeference]
  338. A. Doscher et al. Six new RHD alleles with previously unknown polymorphisms Transfus Med Hemother , 2003. — Abstract — [RHeference]
  339. Reid ME et al. DAK, a new low-incidence antigen in the Rh blood group system. Transfusion, 2003. [Citation] [RHeference]
  340. Noizat-Pirenne F et al. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs. Transfus Clin Biol, 2003. [Citation] [RHeference]
  341. Wagner FF et al. RHD allele distribution in Africans of Mali. BMC Genet, 2003. [Citation] [RHeference]
  342. Cannon M et al. Fatal hydrops fetalis caused by anti-D in a mother with partial D. Obstet Gynecol, 2003. [Citation] [RHeference]
  343. Perco P et al. Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type. Transfusion, 2003. [Citation] [RHeference]
  344. Lin IL et al. Molecular basis of weak D in Taiwanese. Ann Hematol, 2003. [Citation] [RHeference]
  345. Kamesaki T et al. A novel mutation in the RHD gene in Japanese individuals with weak D, encoding an amino acid change in the 11th transmembranous domain of the RhD protein. Vox Sang, 2003. [Citation] [RHeference]
  346. Shao CP et al. [The family investigation of an RHD 270A allele carrier]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2003. [Citation] [RHeference]
  347. Lee YL et al. Analysis of RHD genes in Taiwanese RhD-negative donors by the multiplex PCR method. J Clin Lab Anal, 2003. [Citation] [RHeference]
  348. Shao CP et al. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang, 2002. [Citation] [RHeference]
  349. Rodrigues A et al. Presence of the RHD pseudogene and the hybrid RHD-CE-D(s) gene in Brazilians with the D-negative phenotype. Braz J Med Biol Res, 2002. [Citation] [RHeference]
  350. Ekman GC et al. Rh genotyping: avoiding false-negative and false-positive results among individuals of African ancestry. Am J Hematol, 2002. [Citation] [RHeference]
  351. M. J. Rodrigues et al. Identification of partial D antigen, DBT, with allo-anti-D in the serum Transfusion Medicine, 2002. — Abstract — [RHeference]
  352. Omi T et al. Isolation, characterization, and family study of DTI, a novel partial D phenotype affecting the fourth external loop of D polypeptides. Transfusion, 2002. [Citation] [RHeference]
  353. Wagner FF et al. DNB: a partial D with anti-D frequent in Central Europe. Blood, 2002. [Citation] [RHeference]
  354. Noizat-Pirenne F et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood, 2002. [Citation] [RHeference]
  355. Flegel WA et al. Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfus Clin Biol, 2002. [Citation] [RHeference]
  356. Wagner FF et al. The DAU allele cluster of the RHD gene. Blood, 2002. [Citation] [RHeference]
  357. Singleton BK. Green CA et al. Two new RHD mutations associated with the DEL phenotype Transfusion Clinique et Biologique, 2001. — Abstract — [RHeference]
  358. Esteban R et al. RhD epitope expression in a RHD negative individual: characterization of a novel RHCE variant allele. Transfusion Clinique et Biologique, 2001. — Abstract — [RHeference]
  359. Xu Q et al. [Study on polymorphism of D gene exons among RhD-negative Chinese Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2001. [Citation] [RHeference]
  360. Wagner FF et al. A D(V)-like phenotype is obliterated by A226P in the partial D DBS. Transfusion, 2001. [Citation] [RHeference]
  361. Müller TH et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion, 2001. [Citation] [RHeference]
  362. Kashiwase K et al. E variants found in Japanese and c antigenicity alteration without substitution in the second extracellular loop. Transfusion, 2001. [Citation] [RHeference]
  363. Noizat-Pirenne F et al. DAL: a new partial RHD phenotype. Transfusion, 2001. [Citation] [RHeference]
  364. Faas BH et al. Partial expression of RHc on the RHD polypeptide. Transfusion, 2001. [Citation] [RHeference]
  365. Kamesaki T et al. Molecular characterization of weak D phenotypes by site-directed mutagenesis and expression of mutant Rh-green fluorescence protein fusions in K562 cells. Vox Sang, 2001. [Citation] [RHeference]
  366. Legler TJ et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med, 2001. [Citation] [RHeference]
  367. Wagner FF et al. RHD positive haplotypes in D negative Europeans. BMC Genet, 2001. [Citation] [RHeference]
  368. Singleton BK et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood, 2000. [Citation] [RHeference]
  369. Cowley NM et al. RHD gene mutations and the weak D phenotype: an Australian blood donor study. Vox Sang, 2000. [Citation] [RHeference]
  370. Hyodo H et al. New RhD(IVb) identified in Japanese. Vox Sang, 2000. [Citation] [RHeference]
  371. Hyodo H et al. Polymorphisms of RhD(Va) and a new RhD(Va)-like variant found in Japanese individuals. Vox Sang, 2000. [Citation] [RHeference]
  372. Omi T et al. Detection of Rh23 in the partial D phenotype associated with the D(Va) category. Transfusion, 2000. [Citation] [RHeference]
  373. Legler TJ et al. D(Va) category phenotype and genotype in Japanese families. Vox Sang, 2000. [Citation] [RHeference]
  374. Avent ND et al. The Rh blood group system: a review. Blood, 2000. [Citation] [RHeference]
  375. Okuda H et al. The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE genes through complete sequencing. Biochem Biophys Res Commun, 2000. [Citation] [RHeference]
  376. Wagner FF et al. Weak D alleles express distinct phenotypes. Blood, 2000. [Citation] [RHeference]
  377. Flegel WA et al. Primary anti-D immunization by weak D type 2 RBCs. Transfusion, 2000. [Citation] [RHeference]
  378. Wagner FF et al. RHD gene deletion occurred in the Rhesus box. Blood, 2000. [Citation] [RHeference]
  379. Avent ND et al. The rhesus blood group system: insights from recent advances in molecular biology. Transfus Med Rev, 1999. [Citation] [RHeference]
  380. Huang CH et al. Evidence for a separate genetic origin of the partial D phenotype DBT in a Japanese family. Transfusion, 1999. [Citation] [RHeference]
  381. Wagner FF et al. Molecular basis of weak D phenotypes. Blood, 1999. [Citation] [RHeference]
  382. Liu W et al. Site-directed mutagenesis of the human D antigen: definition of D epitopes on the sixth external domain of the D protein expressed on K562 cells. Transfusion, 1999. [Citation] [RHeference]
  383. Omi T et al. The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype. Biochem Biophys Res Commun, 1999. [Citation] [RHeference]
  384. Hemker MB et al. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood, 1999. [Citation] [RHeference]
  385. Chérif-Zahar B et al. Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. Br J Haematol, 1998. [Citation] [RHeference]
  386. Chang JG et al. Human RhDel is caused by a deletion of 1,013 bp between introns 8 and 9 including exon 9 of RHD gene. Blood, 1998. [Citation] [RHeference]
  387. Andrews KT et al. The RhD- trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene. Blood, 1998. [Citation] [RHeference]
  388. Daniels GL et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion, 1998. [Citation] [RHeference]
  389. Reid ME et al. Use of LOR-15C9 monoclonal anti-D to differentiate erythrocytes with the partial DvI antigen from those with either partial D antigens or weak D antigens. Immunohematology, 1998. [Citation] [RHeference]
  390. Reid ME et al. Two examples of an inseparable antibody that reacts equally well with DW+ and Rh32+ red blood cells. Vox Sang, 1998. [Citation] [RHeference]
  391. Legler TJ et al. RHD genotyping in weak D phenotypes by multiple polymerase chain reactions. Transfusion, 1998. [Citation] [RHeference]
  392. Wagner FF et al. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood, 1998. [Citation] [RHeference]
  393. Maaskant-van Wijk PA et al. Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion, 1998. [Citation] [RHeference]
  394. Okuda H et al. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest, 1997. [Citation] [RHeference]
  395. Faas BH et al. Molecular background of VS and weak C expression in blacks. Transfusion, 1997. [Citation] [RHeference]
  396. Gassner C et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion, 1997. [Citation] [RHeference]
  397. Wallace M et al. DBT: a partial D phenotype associated with the low-incidence antigen Rh32. Transfus Med, 1997. [Citation] [RHeference]
  398. Matassi G et al. Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the D(VI) phenotype. Am J Hum Genet, 1997. [Citation] [RHeference]
  399. Jones JW et al. The serological profile and molecular basis of a new partial D phenotype, DHR. Vox Sang, 1997. [Citation] [RHeference]
  400. Avent ND et al. Molecular basis of the D variant phenotypes DNU and DII allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D protein. Br J Haematol, 1997. [Citation] [RHeference]
  401. Huang CH et al. Human D(IIIa) erythrocytes: RhD protein is associated with multiple dispersed amino acid variations. Am J Hematol, 1997. [Citation] [RHeference]
  402. Maaskant-van Wijk PA et al. Evidence That the RHDVI Deletion Genotype Does Not Exist Blood, 1997. [Citation] [RHeference]
  403. Avent ND et al. Molecular analysis of Rh transcripts and polypeptides from individuals expressing the DVI variant phenotype: an RHD gene deletion event does not generate All DVIccEe phenotypes. Blood, 1997. [Citation] [RHeference]
  404. Huang CH et al. Human DVI category erythrocytes: correlation of the phenotype with a novel hybrid RhD-CE-D gene but not an internally deleted RhD gene. Blood, 1997. [Citation] [RHeference]
  405. Avent ND et al. Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood, 1997. [Citation] [RHeference]
  406. Beckers EA et al. The R0Har RH:33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene. Br J Haematol, 1996. [Citation] [RHeference]
  407. Hazenberg CA et al. Hemolytic disease of the newborn caused by alloanti-D from an R0Har r Rh:33 mother. Transfusion, 1996. [Citation] [RHeference]
  408. Beckers EA et al. The RoHar antigenic complex is associated with a limited number of D epitopes and alloanti-D production: a study of three unrelated persons and their families. Transfusion, 1996. [Citation] [RHeference]
  409. Wallace M et al. The D antigen characteristic of RoHar is a partial D antigen. Vox Sang, 1996. [Citation] [RHeference]
  410. Liu et al. Molecular analysis of two D-variants, DHMi and DHMii. Transfusion Medicine, 1996. — Abstract — [RHeference]
  411. Faas BH et al. Involvement of Ser103 of the Rh polypeptides in G epitope formation. Transfusion, 1996. [Citation] [RHeference]
  412. Beckers EA et al. The genetic basis of a new partial D antigen: DDBT. Br J Haematol, 1996. [Citation] [RHeference]
  413. Tippett P et al. The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang, 1996. [Citation] [RHeference]
  414. Jones J et al. Selection of monoclonal antibodies for the identification of D variants: ability to detect weak D and to split epD2, epD5 and epD6/7. Vox Sang, 1996. [Citation] [RHeference]
  415. Cartron JP et al. Tentative model for the mapping of D epitopes on the RhD polypeptide. Transfus Clin Biol, 1996. [Citation] [RHeference]
  416. Scott M et al. Rh serology--coordinator's report. Transfus Clin Biol, 1996. [Citation] [RHeference]
  417. Flegel WA et al. RHD epitope density profiles of RHD variant red cells analyzed by flow cytometry. Transfus Clin Biol, 1996. [Citation] [RHeference]
  418. Noizat-Pirenne F et al. Molecular analysis of selected Rh variants. Transfus Clin Biol, 1996. [Citation] [RHeference]
  419. Beckers EA et al. Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype. Transfusion, 1996. [Citation] [RHeference]
  420. Scott ML et al. A structural model for 30 Rh D epitopes based on serological and DNA sequence data from partial D phenotypes. Transfus Clin Biol, 1996. [Citation] [RHeference]
  421. Avent ND et al. Molecular biology of partial D phenotypes. Transfus Clin Biol, 1996. [Citation] [RHeference]
  422. Huang CH et al. Alteration of RH gene structure and expression in human dCCee and DCW-red blood cells: phenotypic homozygosity versus genotypic heterozygosity. Blood, 1996. [Citation] [RHeference]
  423. Armstrong-Fisher SS et al. Molecular analysis of DVI variant ISBT 35 (R2VIr). Transfus Clin Biol, 1996. [Citation] [RHeference]
  424. Rouillac C et al. Molecular basis of the altered antigenic expression of RhD in weak D(Du) and RhC/e in RN phenotypes. Blood, 1996. [Citation] [RHeference]
  425. Jones JW et al. Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry. Vox Sang, 1996. [Citation] [RHeference]
  426. Huang CH et al. Identification of a partial internal deletion in the RH locus causing the human erythrocyte D--phenotype. Blood, 1995. [Citation] [RHeference]
  427. Rouillac C et al. Transcript analysis of D category phenotypes predicts hybrid Rh D-CE-D proteins associated with alteration of D epitopes. Blood, 1995. [Citation] [RHeference]
  428. Jones J et al. Identification of two new D variants, DHMi and DHMii using monoclonal anti-D. Vox Sang, 1995. [Citation] [RHeference]
  429. Rouillac C et al. Lack of G blood group antigen in DIIIb erythrocytes is associated with segmental DNA exchange between RH genes. Br J Haematol, 1995. [Citation] [RHeference]
  430. Wagner FF et al. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. Infusionsther Transfusionsmed, 1995. [Citation] [RHeference]
  431. Rouillac C et al. Leu110Pro substitution in the RhD polypeptide is responsible for the DVII category blood group phenotype. Am J Hematol, 1995. [Citation] [RHeference]
  432. Simsek S et al. Rapid Rh D genotyping by polymerase chain reaction-based amplification of DNA. Blood, 1995. [Citation] [RHeference]
  433. Hyland CA et al. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes. Blood, 1994. [Citation] [RHeference]
  434. Blunt T et al. Serotype switching in a partially deleted RHD gene. Vox Sang, 1994. [Citation] [RHeference]
  435. Chérif-Zahar B et al. Molecular analysis of the structure and expression of the RH locus in individuals with D--, Dc-, and DCw- gene complexes. Blood, 1994. [Citation] [RHeference]
  436. Lomas C et al. FPTT is a low-incidence Rh antigen associated with a "new" partial Rh D phenotype, DFR. Transfusion, 1994. [Citation] [RHeference]
  437. Mouro I et al. Rearrangements of the blood group RhD gene associated with the DVI category phenotype. Blood, 1994. [Citation] [RHeference]
  438. Wagner F et al. [Occurrence of D category VI in blood donors in Baden-Württemberg]. Beitr Infusionsther Transfusionsmed, 1994. [Citation] [RHeference]
  439. Lomas C et al. Further complexities of the Rh antigen D disclosed by testing category DII cells with monoclonal anti-D. Transfus Med, 1993. [Citation] [RHeference]
  440. Gorick B et al. Quantitation of D sites on selected 'weak D' and 'partial D' red cells. Vox Sang, 1993. [Citation] [RHeference]
  441. Lomas C et al. Abolition of the DVc subcategory. Transfusion, 1993. [Citation] [RHeference]
  442. Arce MA et al. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood, 1993. [Citation] [RHeference]
  443. Le van Kim C et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci U S A, 1992. [Citation] [RHeference]
  444. Hartel-Schenk S et al. Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex. J Biol Chem, 1992. [Citation] [RHeference]
  445. López López C et al. [Testicular torsion. The first manifestation of polyorchidism]. Actas Urol Esp, 1992. [Citation] [RHeference]
  446. Okubo Y et al. Partial D antigens disclosed by a monoclonal anti-D in Japanese blood donors. Transfusion, 1991. [Citation] [RHeference]
  447. Colin Y et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood, 1991. [Citation] [RHeference]
  448. Tippett P et al. Monoclonal antibodies against Rh and Rh related antigens. J Immunogenet, 1990. [Citation] [RHeference]
  449. Mayne K et al. Rh immunization by the partial D antigen of category DVa. Br J Haematol, 1990. [Citation] [RHeference]
  450. Leader KA et al. Human monoclonal anti-D with reactivity against category DVI cells used in blood grouping and determination of the incidence of the category DVI phenotype in the DU population. Vox Sang, 1990. [Citation] [RHeference]
  451. Le Pennec PY et al. A serologic study of red cells and sera from 18 Rh:32,-46 (RN/RN) persons. Transfusion, 1989. [Citation] [RHeference]
  452. Lomas C et al. Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories. Vox Sang, 1989. [Citation] [RHeference]
  453. Merry AH et al. Variation in the level of Rh(D) antigen expression. Transfusion, 1988. [Citation] [RHeference]
  454. Issitt PD et al. Anti-Rh33, the second separable example, also made by a person who made anti-D and has C+ red cells. Transfusion, 1986. [Citation] [RHeference]
  455. Okubo Y et al. A D variant, Del? Transfusion, 1984. [Citation] [RHeference]
  456. Lacey PA et al. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion, 1983. [Citation] [RHeference]
  457. National Center for Biotechnology Information et al. Data from Genbank submission Online ressource, 1982. — Online ressource — [RHeference]
  458. Lewis M et al. Assignment of the red cell antigen, Targett (Rh40), to the Rh blood group system. Am J Hum Genet, 1979. [Citation] [RHeference]
  459. Lalezari P et al. Development of direct antiglobulin reaction accompanying alloimmunization in a patient with Rhd (D, category III) phenotype. Vox Sang, 1975. [Citation] [RHeference]
  460. Giles CM et al. An Rh gene complex which results in a "new" antigen detectable by a specific antibody, Anti-Rh 33. Vox Sang, 1971. [Citation] [RHeference]
  461. Salmon C et al. [The gene complex DIV (C)-]. Rev Fr Transfus, 1969. [Citation] [RHeference]
  462. CHOWN B et al. A "D-POSITIVE" MAN WHO PRODUCED ANTI-D. Vox Sang, 1963. [Citation] [RHeference]
  463. TIPPETT P et al. Observations on subdivisions of the Rh antigen D. Vox Sang, 1962. [Citation] [RHeference]
  464. ROSENFIELD RE et al. Problems in Rh typing as revealed by a single Negro family. Am J Hum Genet, 1960. [Citation] [RHeference]
  465. FRANCIS BJ et al. An Rh-o (D) positive patient whose serum contains anti-Rh-o (D) antibodies. Family studies. Vox Sang, 1960. [Citation] [RHeference]
  466. Ceppellini R et al. AN INTERACTION BETWEEN ALLELES AT THE RH LOCUS IN MAN WHICH WEAKENS THE REACTIVITY OF THE RH(0) FACTOR (D). Proc Natl Acad Sci U S A, 1955. [Citation] [RHeference]
  467. International Society of Blood Transfusion et al. International Society of Blood Transfusion (ISBT) allele table Online ressource, 1935. — Online ressource — [RHeference]